These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 23229280)

  • 1. Role of KCNJ5 in familial and sporadic primary aldosteronism.
    Mulatero P; Monticone S; Rainey WE; Veglio F; Williams TA
    Nat Rev Endocrinol; 2013 Feb; 9(2):104-12. PubMed ID: 23229280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI; Lifton RP
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
    Murthy M; Xu S; Massimo G; Wolley M; Gordon RD; Stowasser M; O'Shaughnessy KM
    Hypertension; 2014 Apr; 63(4):783-9. PubMed ID: 24420545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A revised mechanism of action of hyperaldosteronism-linked mutations in cytosolic domains of GIRK4 (KCNJ5).
    Shalomov B; Handklo-Jamal R; Reddy HP; Theodor N; Bera AK; Dascal N
    J Physiol; 2022 Mar; 600(6):1419-1437. PubMed ID: 34957562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
    Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary aldosteronism: new insights into familial forms].
    van den Meiracker AH; van der Linde AA; Claahsen van der Grinten HL; Danser AH; Deinum J
    Ned Tijdschr Geneeskd; 2015; 159():A8932. PubMed ID: 26420144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.
    Mulatero P; Tauber P; Zennaro MC; Monticone S; Lang K; Beuschlein F; Fischer E; Tizzani D; Pallauf A; Viola A; Amar L; Williams TA; Strom TM; Graf E; Bandulik S; Penton D; Plouin PF; Warth R; Allolio B; Jeunemaitre X; Veglio F; Reincke M
    Hypertension; 2012 Feb; 59(2):235-40. PubMed ID: 22203740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic causes of primary aldosteronism.
    Seidel E; Schewe J; Scholl UI
    Exp Mol Med; 2019 Nov; 51(11):1-12. PubMed ID: 31695023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy?
    Gomez-Sanchez CE; Oki K
    Endocrinology; 2014 Jan; 155(1):47-55. PubMed ID: 24248457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
    Oki K; Plonczynski MW; Luis Lam M; Gomez-Sanchez EP; Gomez-Sanchez CE
    Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary aldosteronism and potassium channel mutations.
    Stowasser M
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):170-9. PubMed ID: 23426162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.
    Aristizabal Prada ET; Castellano I; Sušnik E; Yang Y; Meyer LS; Tetti M; Beuschlein F; Reincke M; Williams TA
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
    Choi M; Scholl UI; Yue P; Björklund P; Zhao B; Nelson-Williams C; Ji W; Cho Y; Patel A; Men CJ; Lolis E; Wisgerhof MV; Geller DS; Mane S; Hellman P; Westin G; Åkerström G; Wang W; Carling T; Lifton RP
    Science; 2011 Feb; 331(6018):768-72. PubMed ID: 21311022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
    Hattangady NG; Karashima S; Yuan L; Ponce-Balbuena D; Jalife J; Gomez-Sanchez CE; Auchus RJ; Rainey WE; Else T
    J Mol Endocrinol; 2016 Jul; 57(1):1-11. PubMed ID: 27099398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hyperaldosteronism type III a novel case and review of literature.
    Pons Fernández N; Moreno F; Morata J; Moriano A; León S; De Mingo C; Zuñiga Á; Calvo F
    Rev Endocr Metab Disord; 2019 Mar; 20(1):27-36. PubMed ID: 30569443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.
    Charmandari E; Sertedaki A; Kino T; Merakou C; Hoffman DA; Hatch MM; Hurt DE; Lin L; Xekouki P; Stratakis CA; Chrousos GP
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1532-9. PubMed ID: 22628607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
    Boulkroun S; Beuschlein F; Rossi GP; Golib-Dzib JF; Fischer E; Amar L; Mulatero P; Samson-Couterie B; Hahner S; Quinkler M; Fallo F; Letizia C; Allolio B; Ceolotto G; Cicala MV; Lang K; Lefebvre H; Lenzini L; Maniero C; Monticone S; Perrocheau M; Pilon C; Plouin PF; Rayes N; Seccia TM; Veglio F; Williams TA; Zinnamosca L; Mantero F; Benecke A; Jeunemaitre X; Reincke M; Zennaro MC
    Hypertension; 2012 Mar; 59(3):592-8. PubMed ID: 22275527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
    Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
    Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.